Physician profile
Dafna Lebow
NPI 1881674927
$1,544.74
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $812 · 2020: $366 · 2021: $320 · 2022: $46.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $665.77 | 2019-2022 | |
| Abbvie INC. | $253.18 | 2019-2022 | |
| Coloplast Corp | $152.71 | 2020 | |
| Avion Pharmaceuticals | $90.92 | 2019-2021 | |
| Evofem Biosciences, INC. | $63.59 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $45.19 | 2019 | |
| Therapeuticsmd, INC. | $40.81 | 2019-2021 | |
| Pfizer INC. | $37.70 | 2021 | |
| Mayne Pharma Commercial LLC | $35.65 | 2021 | |
| Lupin INC. | $32.52 | 2019-2020 | |
| Allergan, INC. | $28.96 | 2019-2020 | |
| Millicent US INC | $20.55 | 2019 | |
| Minerva Surgical, INC | $20.12 | 2020 | |
| Myovant Sciences INC. | $15.85 | 2021 | |
| Coopersurgical, INC. | $14.55 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $13.46 | 2019 | |
| Boston Scientific Corporation | $13.21 | 2021 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dafna Lebow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.